Key Insights
The Europe pharmaceutical plastic packaging market, valued at approximately €13.69 billion in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 5.17% from 2025 to 2033. This expansion is driven by several key factors. Firstly, the increasing prevalence of chronic diseases across Europe necessitates a higher demand for pharmaceutical products, consequently boosting the need for safe and effective packaging solutions. Secondly, the growing preference for convenient and user-friendly drug delivery systems, such as pre-filled syringes and blister packs, fuels the demand for specialized plastic packaging. Furthermore, stringent regulatory requirements regarding drug safety and tamper-evidence are driving innovation in packaging materials and designs, leading to premium packaging options and market growth. Finally, the pharmaceutical industry's ongoing efforts to reduce its environmental footprint are pushing the adoption of sustainable and recyclable plastic packaging materials, further shaping market dynamics.
However, the market faces some challenges. Fluctuations in raw material prices, particularly petroleum-based plastics, can impact production costs and profitability. Additionally, increasing environmental concerns regarding plastic waste and its impact on ecosystems could lead to regulatory changes or consumer preferences that favour alternative packaging materials. Despite these restraints, the market's positive outlook is maintained by the continuous development of innovative packaging technologies, such as active and intelligent packaging, designed to enhance drug stability, extend shelf life, and improve patient compliance. The competitive landscape features major players like Gerresheimer AG, Amcor PLC, and Berry Global Group Inc., amongst others, all actively contributing to market growth through product diversification and strategic partnerships. The market's segmentation likely includes various types of packaging (bottles, blisters, pouches, etc.), materials (PET, HDPE, PVC, etc.), and end-use applications (tablets, capsules, injectables, etc.), each with its unique growth trajectory.
This in-depth report provides a comprehensive analysis of the Europe Pharmaceutical Plastic Packaging Market, encompassing market dynamics, growth trends, regional performance, product landscape, and key players. The study covers the period from 2019 to 2033, with a focus on the forecast period 2025-2033 and a base year of 2025. The report is designed to equip industry professionals, investors, and stakeholders with actionable insights to navigate this dynamic market. The total market value in 2025 is estimated at xx Million units.
Target Audience: Pharmaceutical companies, packaging manufacturers, investors, regulatory bodies, and market research firms.
Parent Market: European Pharmaceutical Packaging Market Child Market: Plastic Pharmaceutical Packaging

Europe Pharmaceutical Plastic Packaging Market Market Dynamics & Structure
The European pharmaceutical plastic packaging market is characterized by moderate concentration, with several major players and a multitude of smaller regional companies. Technological innovation, driven by the need for enhanced drug stability, security, and patient convenience, is a key market driver. Stringent regulatory frameworks, including those related to material safety and environmental sustainability, significantly influence market dynamics. The increasing adoption of sustainable and eco-friendly packaging materials is reshaping the competitive landscape. The market also witnesses significant M&A activity, reflecting the ongoing consolidation among market players.
- Market Concentration: Moderately concentrated, with top 10 players holding approximately xx% market share in 2025.
- Technological Innovation: Focus on barrier technologies, smart packaging, and sustainable materials.
- Regulatory Framework: Stringent regulations concerning material safety, recyclability, and labeling.
- Competitive Substitutes: Glass and other materials present limited but significant competition.
- End-User Demographics: Dominated by large multinational pharmaceutical companies and increasing demand from smaller niche players.
- M&A Trends: Significant consolidation activity, with an estimated xx M&A deals in the last 5 years.
Europe Pharmaceutical Plastic Packaging Market Growth Trends & Insights
The European pharmaceutical plastic packaging market is expected to exhibit steady growth throughout the forecast period. Driven by factors such as the rising demand for pharmaceutical products, increasing preference for convenient packaging formats, and technological advancements in materials science, the market is poised for expansion. The Compound Annual Growth Rate (CAGR) is projected to be xx% between 2025 and 2033. Market penetration of innovative packaging solutions is steadily increasing, with a projected xx% increase in adoption by 2033. Consumer behavior shifts towards personalized medicine and increased demand for home healthcare are also contributing to market growth.

Dominant Regions, Countries, or Segments in Europe Pharmaceutical Plastic Packaging Market
Western Europe, particularly Germany, France, and the UK, are expected to dominate the market owing to a strong pharmaceutical industry presence, advanced healthcare infrastructure, and high disposable incomes. However, significant growth potential exists in Eastern European countries due to increasing pharmaceutical production and healthcare spending. The segment of blister packaging is expected to hold a significant share of the market owing to its cost-effectiveness and widespread use.
- Key Drivers:
- Strong pharmaceutical industry in Western Europe.
- Increasing healthcare spending across the region.
- Rising demand for convenient and safe packaging solutions.
- Favorable regulatory environment in specific countries.
- Dominant Regions: Western Europe (Germany, France, UK) hold xx% market share, while Eastern Europe is projected to grow at xx% CAGR.
- Dominant Segments: Blister packs dominate, with xx% market share in 2025.
Europe Pharmaceutical Plastic Packaging Market Product Landscape
The market offers a wide range of plastic packaging solutions, including blister packs, bottles, vials, tubes, and pouches, each designed to meet specific pharmaceutical product requirements. Recent innovations focus on enhanced barrier properties to improve drug stability, tamper-evident features to ensure product security, and sustainable materials to meet environmental regulations. Key performance metrics include barrier properties, ease of use, recyclability, and cost-effectiveness.
Key Drivers, Barriers & Challenges in Europe Pharmaceutical Plastic Packaging Market
Key Drivers:
- Growing pharmaceutical production and drug discovery.
- Increasing demand for convenient and safe packaging solutions.
- Technological advancements in sustainable and functional packaging materials.
- Stringent regulatory requirements driving innovation in material science.
Key Challenges:
- Fluctuating raw material prices impacting profitability.
- Stringent environmental regulations and the need for sustainable packaging solutions.
- Intense competition from established and emerging players.
- Supply chain disruptions impacting timely delivery of packaging materials. (Estimated xx% impact on market growth in 2024 due to supply chain issues).
Emerging Opportunities in Europe Pharmaceutical Plastic Packaging Market
- Growing demand for personalized medicine packaging.
- Increasing adoption of smart packaging incorporating technology for traceability and security.
- Rising interest in eco-friendly and recyclable packaging solutions.
- Untapped market potential in Eastern European countries.
Growth Accelerators in the Europe Pharmaceutical Plastic Packaging Market Industry
Technological breakthroughs in barrier technologies, sustainable materials, and smart packaging are driving market expansion. Strategic partnerships and collaborations between packaging manufacturers and pharmaceutical companies facilitate innovation and market penetration. Market expansion strategies focusing on emerging markets and product diversification contribute to long-term growth.
Key Players Shaping the Europe Pharmaceutical Plastic Packaging Market Market
- Gerresheimer AG
- Amcor PLC
- Berry Global Group Inc
- Aptar Group Inc
- Origin Pharma Packaging
- Pretium Packaging
- Klockner Pentaplast
- Comar
- Gil Plastic Products Ltd
- Drug Plastics Group
- West Pharmaceutical Services Inc
Notable Milestones in Europe Pharmaceutical Plastic Packaging Market Sector
- May 2024: Gerresheimer Glas GmbH acquires Bormioli Pharma Group, expanding its portfolio in plastic pharmaceutical primary packaging.
- February 2024: Aptar CSP Technologies and ProAmpac launch ProActive Intelligence Moisture Protect, a next-generation moisture-adsorbing flexible packaging solution.
In-Depth Europe Pharmaceutical Plastic Packaging Market Market Outlook
The future of the European pharmaceutical plastic packaging market looks promising, driven by continuous innovation in materials science, increasing demand for advanced packaging solutions, and the growing focus on sustainability. Strategic partnerships, expansion into new markets, and product diversification will be critical factors in realizing the market's full potential. The market is projected to reach xx Million units by 2033.
Europe Pharmaceutical Plastic Packaging Market Segmentation
-
1. Raw Material
- 1.1. Polypropylene (PP)
- 1.2. Polyethylene Terephthalate (PET)
- 1.3. Low Density Polyethylene (LDPE)
- 1.4. High Density Polyethylene (HDPE)
- 1.5. Other Types of Materials
-
2. Product Type
- 2.1. Solid Containers
- 2.2. Dropper Bottles
- 2.3. Nasal Spray Bottles
- 2.4. Liquid Bottles
- 2.5. Oral Care
- 2.6. Pouches
- 2.7. Vials and Ampoules
- 2.8. Cartridges
- 2.9. Syringes
- 2.10. Caps and Closures
- 2.11. Other Product Types
Europe Pharmaceutical Plastic Packaging Market Segmentation By Geography
-
1. Europe
- 1.1. United Kingdom
- 1.2. Germany
- 1.3. France
- 1.4. Italy
- 1.5. Spain
- 1.6. Netherlands
- 1.7. Belgium
- 1.8. Sweden
- 1.9. Norway
- 1.10. Poland
- 1.11. Denmark

Europe Pharmaceutical Plastic Packaging Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 5.17% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Demand for Rigid and Flexible Pharmaceutical Plastic Products; Development of Better and More Advanced Healthcare Infrastructure
- 3.3. Market Restrains
- 3.3.1. Increasing Demand for Rigid and Flexible Pharmaceutical Plastic Products; Development of Better and More Advanced Healthcare Infrastructure
- 3.4. Market Trends
- 3.4.1. Syringes Segment is Expected to Hold Significant Market Share
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Pharmaceutical Plastic Packaging Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
- 5.1.1. Polypropylene (PP)
- 5.1.2. Polyethylene Terephthalate (PET)
- 5.1.3. Low Density Polyethylene (LDPE)
- 5.1.4. High Density Polyethylene (HDPE)
- 5.1.5. Other Types of Materials
- 5.2. Market Analysis, Insights and Forecast - by Product Type
- 5.2.1. Solid Containers
- 5.2.2. Dropper Bottles
- 5.2.3. Nasal Spray Bottles
- 5.2.4. Liquid Bottles
- 5.2.5. Oral Care
- 5.2.6. Pouches
- 5.2.7. Vials and Ampoules
- 5.2.8. Cartridges
- 5.2.9. Syringes
- 5.2.10. Caps and Closures
- 5.2.11. Other Product Types
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Europe
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Gerresheimer AG
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Amcor PLC
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Berry Global Group Inc
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Aptar Group Inc
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Origin Pharma Packaging
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Pretium Packaging
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Klockner Pentaplast
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Comar
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Gil Plastic Products Ltd
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Drug Plastics Group
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.11 West Pharmaceutical Services Inc
- 6.2.11.1. Overview
- 6.2.11.2. Products
- 6.2.11.3. SWOT Analysis
- 6.2.11.4. Recent Developments
- 6.2.11.5. Financials (Based on Availability)
- 6.2.1 Gerresheimer AG
List of Figures
- Figure 1: Europe Pharmaceutical Plastic Packaging Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Europe Pharmaceutical Plastic Packaging Market Share (%) by Company 2024
List of Tables
- Table 1: Europe Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Europe Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Region 2019 & 2032
- Table 3: Europe Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2019 & 2032
- Table 4: Europe Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2019 & 2032
- Table 5: Europe Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 6: Europe Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type 2019 & 2032
- Table 7: Europe Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Region 2019 & 2032
- Table 8: Europe Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Region 2019 & 2032
- Table 9: Europe Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2019 & 2032
- Table 10: Europe Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2019 & 2032
- Table 11: Europe Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 12: Europe Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type 2019 & 2032
- Table 13: Europe Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Country 2019 & 2032
- Table 14: Europe Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Country 2019 & 2032
- Table 15: United Kingdom Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: United Kingdom Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 17: Germany Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Germany Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 19: France Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: France Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 21: Italy Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Italy Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 23: Spain Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Spain Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 25: Netherlands Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Netherlands Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 27: Belgium Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Belgium Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 29: Sweden Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Sweden Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 31: Norway Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Norway Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 33: Poland Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Poland Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 35: Denmark Europe Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: Denmark Europe Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Pharmaceutical Plastic Packaging Market?
The projected CAGR is approximately 5.17%.
2. Which companies are prominent players in the Europe Pharmaceutical Plastic Packaging Market?
Key companies in the market include Gerresheimer AG, Amcor PLC, Berry Global Group Inc, Aptar Group Inc, Origin Pharma Packaging, Pretium Packaging, Klockner Pentaplast, Comar, Gil Plastic Products Ltd, Drug Plastics Group, West Pharmaceutical Services Inc.
3. What are the main segments of the Europe Pharmaceutical Plastic Packaging Market?
The market segments include Raw Material, Product Type.
4. Can you provide details about the market size?
The market size is estimated to be USD 13.69 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Demand for Rigid and Flexible Pharmaceutical Plastic Products; Development of Better and More Advanced Healthcare Infrastructure.
6. What are the notable trends driving market growth?
Syringes Segment is Expected to Hold Significant Market Share.
7. Are there any restraints impacting market growth?
Increasing Demand for Rigid and Flexible Pharmaceutical Plastic Products; Development of Better and More Advanced Healthcare Infrastructure.
8. Can you provide examples of recent developments in the market?
May 2024: Gerresheimer Glas GmbH, an indirect subsidiary of Gerresheimer AG, signed a purchase agreement with funds advised by Triton to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group. Blitz LuxCo Sarl has a complementary portfolio of plastic pharmaceutical primary packaging, increasing its portfolio in the market studied.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 4950, and USD 6800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Pharmaceutical Plastic Packaging Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Pharmaceutical Plastic Packaging Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Pharmaceutical Plastic Packaging Market?
To stay informed about further developments, trends, and reports in the Europe Pharmaceutical Plastic Packaging Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence